ΣΥΜΒΟΛΗ ΕΙΣ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΙΝ ΤΩΝ ΚΙΡΣΩΝ ΤΩΝ ΚΑΤΩ ΑΚΡΩΝ ΔΙΑ ΣΥΜΠΙΕΣΤΙΚΗΣ ΣΚΛΗΡΟΘΕΡΑΠΕΙΑΣ

Abstract

TREATMENT OF VARICOSE VEINS BY SCLEROTHERAPY WITH COMPRESSION. IN THE PRESENT STUDY 83 PATIENTS WERE TREATED BY COMPRESSION SCLEROTHERAPY FOR VARICOSE VEINS DUE TO INCOMPITENT PERFORATED VEINS. COMPRESSION SCLEROTHERAPY WAS PERFORMED IN THE OUTPATIENTS DEPARTMENT OF THE II SURGICAL CLINIC OF GENERAL HOSPITAL OF ATHENS ON AN AMBULATORY BASIS AND THE PATIENTS AFTER EACH TREATMENT WERE ABLE TO CONTINUE THEIR USUAL ACTIVITIES. WE HAVE EVALUATED THE RESULTS OF 83 PATIENTS IN WHOSE 121 LEGS WERE TREATED AND FOLLOWED OVER 2 TO 6 YEARS. THE RESULTS WERE VERY SATISFACTORY IN 84,3 PERCENT WITH TOTAL RELIEF OF SYMPTOMS AS WELL AS GOOD COSMETIC RESULTS. IN 13,2 PERCENT OF THE CASES RECURRENT VARICOSE VEINS OR DEVELOPMENT OF NEW INCOPETENT PERFORATORS WERE NOTICED AND THESE PATIENTS WERE RETREATED BY THE SAME METHOD. SERIOUS COMPLICATIONS, LIKE PULMONARY EMBOLISM OR DEEP VEIN THROMBOSIS WERE AVOIDED BY USING THE NEW SCLEROSIN SOLUTIONS AND INFECTING A SMALL AMMOUNT OF THE SCLEROSANT IN EACH PERFORATOR. COMPARING COMPRESSIVE SCLEROTHERAPY AND SURGERY THIS METHOD HAS CERTAIN ADVANTAGES. ALL PATIENTS CAN BE TREATED IN AND OUT-PATIENTS DEPARTMENT, THEY ARE FULLY MOBIL AND TREATMENT DOES NOT INTERFERE WITH THEIR DAILY OCCUPATION, AVOIDS THENECESSITY OF ANAESTHESIA AND THE COST IS VERY MUCH SMALLER. COMPRESSION SCLEROTHERAPY IS PROPOSED AS AN ALTERNATIVE METHOD OF TREATING PATIENTS WITH VARICOSE VEINS DUE TO INCOPETENT PERFORATORS THAN THE SURGICAL ONE, BECAUSE IN THISMETHOD THE LONG SAPHENOUS VEIN IN PRESERVED AND SUBSEQUENTLY MAY BE USED AS AN ARTERIAL GRAFT.

ΕΙΣ ΤΗΝ ΜΕΤΑ ΧΕΙΡΑΣ ΔΙΑΤΡΙΒΗΝ ΕΜΕΛΕΤΗΘΗ ΜΕΘΟΔΟΣ ΕΦΑΡΜΟΓΗΣ ΣΥΜΠΙΕΣΤΙΚΗΣ ΣΚΛΗΡΟΘΕΡΑΠΕΙΑΣ ΕΠΙ 83 ΑΣΘΕΝΩΝ ΠΑΣΧΟΝΤΩΝ ΕΚ ΚΙΡΣΩΝ, ΤΟΥΤΕΣΤΙΝ ΕΠΙ ΣΥΝΟΛΟΥ 121 ΑΚΡΩΝ. Η ΜΕΘΟΔΟΣ ΑΥΤΗ ΕΦΗΡΜΟΣΘΗ ΕΙΣ ΑΣΘΕΝΕΙΣ ΠΡΟΣΕΡΧΟΜΕΝΟΥΣ ΕΙΣ ΤΟ ΕΞΩΤΕΡΙΚΟΝ ΙΑΤΡΕΙΟΝ ΤΗΣ Β' ΧΕΙΡΟΥΡΓΙΚΗΣ ΚΛΙΝΙΚΗΣ ΤΟΥ ΓΕΝΙΚΟΥ ΝΟΣΟΚΟΜΕΙΟΥ ΑΘΗΝΩΝ, ΩΣ ΚΑΙ ΕΙΣ ΤΟ ΙΔΙΩΤΙΚΟΝ ΙΑΤΡΕΙΟΝ, ΟΙ ΟΠΟΙΟΙ ΚΑΤΑ ΤΗΝ ΔΙΑΡΚΕΙΑΝ ΤΗΣ ΘΕΡΑΠΕΙΑΣ ΤΩΝ ΔΙΕΚΟΠΤΟΝ ΤΗΝ ΕΡΓΑΣΙΑΝ ΤΩΝ. ΔΙΑ ΤΗΝ ΑΞΙΟΛΟΓΗΣΙΝ ΤΩΝ ΑΠΟΤΕΛΕΣΜΑΤΩΝ ΠΑΡΗΚΟΛΟΥΘΗΣΑΜΕΝ ΤΟΥΣ ΕΝ ΛΟΓΩ ΑΣΘΕΝΕΙΣ ΕΠΙ 2 ΕΩΣ 6 ΕΤΗ ΑΠΟ ΤΗΣ ΕΦΑΡΜΟΓΗΣ ΤΗΣ ΘΕΡΑΠΕΙΑΣ. ΕΙΣ ΤΗΝ ΠΑΡΟΥΣΑΝ ΕΡΓΑΣΙΑΝ ΑΝΑΛΥΟΝΤΑΙ ΤΑ ΠΛΕΟΝΕΚΤΗΜΑΤΑ ΤΗΣ ΜΕΘΟΔΟΥ, Η ΟΠΟΙΑ ΠΡΟΤΕΙΝΕΤΑΙ ΩΣ ΕΝΑΛΛΑΚΤΙΚΗ ΘΕΡΑΠΕΙΑ ΤΗΣ ΧΕΙΡΟΥΡΓΙΚΗΣ ΤΟΙΑΥΤΗΣ, ΔΙΑ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΙΝ ΤΩΝ ΚΙΡΣΩΝ ΤΩΝ ΚΑΤΩ ΑΚΡΩΝ, ΟΙ ΟΠΟΙΟΙ ΟΦΕΙΛΟΝΤΑΙ ΕΙΣ ΑΝΕΠΑΡΚΕΙΑΝ ΤΩΝ ΒΑΛΒΙΔΩΝ ΤΩΝ ΔΙΑΤΙΤΡΩΣΩΝ ΦΛΕΒΩΝ ΚΑΙ ΕΝΔΕΧΟΜΕΝΩΣ ΕΙΣ ΕΛΛΕΙΨΙΝ ΤΟΥ ΣΩΛΗΝΟΕΙΔΟΥΣ ΕΛΥΤΡΟΥ ΤΗΣ ΜΕΙΖΟΝΟΣ ΣΑΦΗΝΟΥΣ ΦΛΕΒΟΣ. ΤΑ ΗΜΕΤΕΡΑ ΑΠΟΤΕΛΕΣΜΑΤΑ ΥΠΗΡΞΑΝ ΛΙΑΝ ΙΚΑΝΟΠΟΙΗΤΙΚΑ ΕΙΣ ΠΟΣΟΣΤΟΝ 84,3%, ΑΙ ΔΕ ΕΠΙΠΛΟΚΑΙ ΗΣΑΝ ΑΝΕΥ ΙΔΙΑΙΤΕΡΑΣ ΣΗΜΑΣΙΑΣ ΚΑΙ ΚΥΡΙΩΣ ΤΟΠΙΚΑΙ ΑΝΤΙΔΡΑΣΕΙΣ.